Pauline van Helden

Pauline van Helden has a long and varied work experience. Pauline began in 2000 with a Master Project at the Department of Immunotoxicology at the Institute for Risk Assessment Sciences. In 2001, they completed a Master Project at the Committee on the Safety Assessment of Novel Foods in The Hague for the Health Council of the Netherlands. In 2002, they began a PhD position at Sanquin. In 2007, they became a Postdoctoral Fellow at Baxter BioScience. From 2010 to 2021, they worked at aimm therapeutics, first as a Scientist, then as a Senior Scientist, and finally as a Director of Discovery. In 2021, they became Director of Translational Research at Lava Therapeutics B.V.

Pauline van Helden completed a Bachelors and Masters of Science in Fundamental Biomedical Sciences from Utrecht University between 1997 and 2002. Pauline also attended Rolduc College.